Intraoperative anaphylaxis to gelatin in topical hemostatic agents during anterior spinal fusion: a case report

Spine Journal

Volumn 12, Issue 8, 2012, Pages e1-e6

  Spencer, Hillard T ^a   Hsu, Joyce T ^a   McDonald, Douglas R ^a   Karlin, Lawrence I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Allergy; Anaphylaxis; Floseal; Gelatin; Gelfoam; Hemostatic agents

Indexed keywords

FLOSEAL MATRIX; GELATIN; GELATIN SPONGE; HEMOSTATIC AGENT;

ADOLESCENT; ANAPHYLAXIS; ARTICLE; BLEEDING; CASE REPORT; HUMAN; MALE; MENINGOMYELOCELE; SCOLIOSIS; SPINE FUSION;

ADOLESCENT; ANAPHYLAXIS; BLOOD LOSS, SURGICAL; GELATIN; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HUMANS; MALE; MENINGOMYELOCELE; SCOLIOSIS; SPINAL FUSION;

MLCS; MLOWN;

EID: 84872047910     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2012.08.425     Document Type: Article

References (10)

1. Lew, W.K., Weaver, F.A., Clinical use of topical thrombin as a surgical hemostat. Biologics 2 (2008), 593–599.
2. ¯ Hemostatic Matrix, Baxter Healthcare Corporation, Hayward, CA. Available at: http://www.baxter.com/healthcare_professionals/products/floseal.html. Accessed March 2, 2012.
3. ¯ absorbable gelatin sponge, USP; Pfizer Inc., New York, NY. Available at: http://www.pfizer.com/products/rx/rx_product_gelfoam.jsp. Accessed March 2, 2012.
4. Schwartz, L.B., Metcalfe, D.D., Miller, J.S., et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316 (1987), 1622–1626.
5. Sakaguchi, M., Hori, H., Ebihara, T., et al. Reactivity of the immunoglobulin E in bovine gelatin-sensitive children to gelatins from various animals. Immunology 96 (1999), 286–290.
6. Khoriaty, E., McClain, C.D., Permaul, P., et al. Intraoperative anaphylaxis induced by the gelatin component of thrombin-soaked gelfoam in a pediatric patient. Ann Allergy Asthma Immunol 108 (2012), 209–210.
7. Krupp J, Mahapatra S. Out of the ‘blue’—anaphylaxis during posterior spinal fusion. Abstract CSF107. Presented at: Society for Pediatric Anesthesia/American Academy of Pediatrics: Pediatric Anesthesiology 2011 Meeting, San Diego, CA. Available at: http://www.pedsanesthesia.org/meetings/2011winter/syllabus/submissions/abstracts/casereports/CSF107.pdf. Accessed March 2, 2012.
8. Manufacturer and User Facility Device Experience database (MAUDE). U.S. Food and Drug Administration. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM. Accessed March 2, 2012.
9. Nakayama, T., Aizawa, C., Kuno-Sakai, H., A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 103:2 pt 1 (1999), 321–325.
10. Kuno-Sakai, H., Kimura, M., Removal of gelatin from live vaccines and DTaP—an ultimate solution for vaccine-related gelatin allergy. Biologicals 31 (2003), 245–249.